We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
-16.76%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$847M
AUM Growth
-$205M
Cap. Flow
-$12.1M
Cap. Flow %
-1.43%
Top 10 Hldgs %
27.22%
Holding
257
New
5
Increased
68
Reduced
98
Closed
21

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$1.71M
2
IQV icon
IQVIA
IQV
+$1.69M
3
CVX icon
Chevron
CVX
+$1.45M
4
ZBRA icon
Zebra Technologies
ZBRA
+$1.38M
5
NVST icon
Envista
NVST
+$902K

Top Sells

Rank Stock Value
1
AMT icon
American Tower
AMT
+$2.39M
2
XOM icon
ExxonMobil
XOM
+$1.88M
3
GILD icon
Gilead Sciences
GILD
+$1.5M
4
MRSH
Marsh
MRSH
+$1.49M
5
VZ icon
Verizon
VZ
+$1.3M

Sector Composition

Rank Sector Weight
1 Technology 19.73%
2 Healthcare 17.21%
3 Financials 9.76%
4 Industrials 8.71%
5 Consumer Staples 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROP icon
26
Roper Technologies
ROP
$39.8B
$9.94M 1.17%
31,874
+1,651
+5% +$585K
VWO icon
27
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$9.82M 1.16%
292,616
-1,626
-0.6% -$66.3K
MDY icon
28
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$9.66M 1.14%
36,755
-2,974
-7% -$1.01M
SYK icon
29
Stryker
SYK
$130B
$9.46M 1.12%
56,847
+597
+1% +$117K
GIS icon
30
General Mills
GIS
$19.7B
$9.36M 1.11%
177,325
-10,999
-6% -$581K
CVS icon
31
CVS Health
CVS
$122B
$8.98M 1.06%
151,443
+4,845
+3% +$323K
IJR icon
32
iShares Core S&P Small-Cap ETF
IJR
$112B
$8.92M 1.05%
159,001
-8,667
-5% -$645K
PEP icon
33
PepsiCo
PEP
$190B
$8.9M 1.05%
74,071
+403
+0.5% +$54.5K
ABT icon
34
Abbott
ABT
$187B
$8.23M 0.97%
104,274
-217
-0.2% -$18.1K
VZ icon
35
Verizon
VZ
$196B
$8.09M 0.96%
150,650
-22,636
-13% -$1.3M
QQQ icon
36
Invesco QQQ Trust
QQQ
$481B
$7.56M 0.89%
39,728
+358
+0.9% +$75.8K
DHR icon
37
Danaher
DHR
$144B
$7.1M 0.84%
57,896
-527
-0.9% -$71K
TEL icon
38
TE Connectivity
TEL
$62.6B
$7.02M 0.83%
111,535
-515
-0.5% -$44K
MRK icon
39
Merck
MRK
$318B
$6.97M 0.82%
94,885
-6,377
-6% -$501K
SPGI icon
40
S&P Global
SPGI
$120B
$6.91M 0.82%
28,206
DLTR icon
41
Dollar Tree
DLTR
$25.2B
$6.85M 0.81%
93,281
-1,457
-2% -$124K
IDXX icon
42
Idexx Laboratories
IDXX
$46.2B
$6.28M 0.74%
25,913
+58
+0.2% +$15.1K
GILD icon
43
Gilead Sciences
GILD
$165B
$6.13M 0.72%
82,003
-21,759
-21% -$1.5M
MCD icon
44
McDonald's
MCD
$195B
$6.03M 0.71%
36,487
-777
-2% -$153K
ABBV icon
45
AbbVie
ABBV
$435B
$5.6M 0.66%
73,486
-86
-0.1% -$7.33K
AFL icon
46
Aflac
AFL
$62.6B
$5.47M 0.65%
159,652
-389
-0.2% -$17.8K
JPM icon
47
JPMorgan Chase
JPM
$950B
$5.05M 0.6%
56,097
-928
-2% -$113K
ADBE icon
48
Adobe
ADBE
$105B
$4.98M 0.59%
15,655
+1,451
+10% +$496K
CVX icon
49
Chevron
CVX
$366B
$4.94M 0.58%
68,151
+14,628
+27% +$1.45M
BDX icon
50
Becton Dickinson
BDX
$48.2B
$4.88M 0.58%
21,767
-872
-4% -$215K

Similar funds

Boston Family Office's Q1 2020 Portfolio in Review

As of Q1 2020, Boston Family Office held 257 positions worth $847M, down 20% from $1.05B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Family Office's Q1 2020 filing shows 5 new, 68 increased, 98 reduced and 21 closed positions. Its largest new stake was Boeing: 6,241 shares worth $931K. The largest sale was American Tower, an estimated $2.39M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Boston Family Office's largest Q1 2020 buy was Boeing: 6,241 shares worth $931K.
  • Boston Family Office added most to IQVIA in Q1 2020, an estimated $1.69M increase.
  • Boston Family Office's biggest Q1 2020 reduction was American Tower, cutting an estimated $2.39M.
  • Boston Family Office fully exited Johnson Controls International in Q1 2020, selling an estimated $493K.
  • Boston Family Office's ten largest holdings make up 27% of its $847M portfolio in Q1 2020.
  • Boston Family Office opened 5 new positions and closed 21 in Q1 2020.
  • Boston Family Office's portfolio value fell 20% quarter-over-quarter to $847M.

Based on Boston Family Office's 13F filing for Q1 2020, filed 11 May 2020.